Type-specific Serologic Testing for Herpes Simplex Virus-2
- PMID: 12642003
- DOI: 10.1007/s11908-003-0053-3
Type-specific Serologic Testing for Herpes Simplex Virus-2
Abstract
Genital herpes due to infection with herpes simplex virus-2 (HSV-2) affects an estimated 60 million adults in the United States. Over 90% are unaware of their infection but are at risk of transmitting HSV to partners. This ongoing "silent" disease is responsible for the continued increase in HSV prevalence. The recent advent of type-specific serologic tests has allowed accurate differentiation of HSV-1 and HSV-2 infection. Screening of at-risk populations will allow identification of individuals with genital herpes and provide an opportunity for risk reduction counseling and interventions to reduce transmission.
Similar articles
-
Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.Int J Dermatol. 1996 Nov;35(11):794-6. doi: 10.1111/j.1365-4362.1996.tb02976.x. Int J Dermatol. 1996. PMID: 8915732
-
Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Dec 20;316(23):2525-2530. doi: 10.1001/jama.2016.16776. JAMA. 2016. PMID: 27997659
-
Type-specific testing for herpes simplex virus.Expert Rev Mol Diagn. 2004 Jul;4(4):443-53. doi: 10.1586/14737159.4.4.443. Expert Rev Mol Diagn. 2004. PMID: 15225092
-
Herpes simplex virus-2 infection. An emerging disease?Infect Dis Clin North Am. 1998 Mar;12(1):47-61. doi: 10.1016/s0891-5520(05)70408-6. Infect Dis Clin North Am. 1998. PMID: 9494829 Review.
-
Reducing the risk of transmitting genital herpes: advances in understanding and therapy.Curr Med Res Opin. 2005 Oct;21(10):1577-82. doi: 10.1185/030079905X61901. Curr Med Res Opin. 2005. PMID: 16238897 Review.
References
LinkOut - more resources
Full Text Sources